These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 1417020)
1. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report. Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Berne B Arch Dermatol; 1992 Oct; 128(10):1341-4. PubMed ID: 1417020 [TBL] [Abstract][Full Text] [Related]
2. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy. Shephard SE; Panizzon RG Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574 [TBL] [Abstract][Full Text] [Related]
3. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA. Hannuksela A; Pukkala E; Hannuksela M; Karvonen J J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561 [TBL] [Abstract][Full Text] [Related]
4. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Halder RM; Battle EF; Smith EM Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934 [No Abstract] [Full Text] [Related]
6. Bath PUVA--an investigation of the distribution of trioxsalen (TMP) and 8-methoxypsoralen (8-MOP) in bathwater. Wainwright NJ; MacLeod TM; Ferguson J Photodermatol Photoimmunol Photomed; 1997; 13(1-2):17-20. PubMed ID: 9361123 [TBL] [Abstract][Full Text] [Related]
7. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen. Koulu L; Jansén CT Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328 [TBL] [Abstract][Full Text] [Related]
8. PUVA therapy for polymorphous light eruptions: comparison of systemic methoxsalen and topical trioxsalen regimens and evaluation of local protective mechanisms. Jansén CT; Karvonen J; Malmiharju T Acta Derm Venereol; 1982; 62(4):317-20. PubMed ID: 6183864 [TBL] [Abstract][Full Text] [Related]
9. The carcinogenic properties of topical PUVA. A lifelong study in mice. Hannuksela M; Stenbäck F; Lahti A Arch Dermatol Res; 1986; 278(5):347-51. PubMed ID: 3753032 [TBL] [Abstract][Full Text] [Related]
10. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization. Koulu LM; Jansén CT J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374 [TBL] [Abstract][Full Text] [Related]
11. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA. Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595 [TBL] [Abstract][Full Text] [Related]
12. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis. Turjanmaa K; Salo H; Reunala T Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716 [TBL] [Abstract][Full Text] [Related]
13. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen. Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009 [TBL] [Abstract][Full Text] [Related]
14. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients. Berne B; Fischer T; Michaëlsson G; Norén P Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278 [TBL] [Abstract][Full Text] [Related]
15. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677 [TBL] [Abstract][Full Text] [Related]
16. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. van Coevorden AM; Kamphof WG; van Sonderen E; Bruynzeel DP; Coenraads PJ Arch Dermatol; 2004 Dec; 140(12):1463-6. PubMed ID: 15611423 [TBL] [Abstract][Full Text] [Related]
17. The effect of PUVA on langerhans cells in rat oral epithelium photosensitized with systemic methoxsalen or topical trioxsalen. Kuusilehto A; Happonen RP; Peltola J; Lehtinen R; Jansén CT Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):129-33. PubMed ID: 10885443 [TBL] [Abstract][Full Text] [Related]
18. PUVA and cancer risk: the Swedish follow-up study. Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523 [TBL] [Abstract][Full Text] [Related]
19. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B. Man I; Dawe RS; Ferguson J; Ibbotson SH Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749 [TBL] [Abstract][Full Text] [Related]
20. Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study. Stern RS; Nichols KT J Pediatr; 1996 Dec; 129(6):915-7. PubMed ID: 8969737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]